Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Queensland Health
Cantor Fitzgerald
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,495,534

« Back to Dashboard

Which drugs does patent 6,495,534 protect, and when does it expire?

Patent 6,495,534 protects DEPO-SUBQ PROVERA 104 and is included in one NDA.

This patent has forty patent family members in twenty-nine countries.

Summary for Patent: 6,495,534

Title: Stabilized aqueous suspensions for parenteral use
Abstract:A pharmaceutical aqueous suspension formulation for parenteral administration having substantially stabilized pH, comprising a biologically active compound and a pH controlling effective concentration of L-Methionine. Preferably, the biologically active compound is a steroidal compound, for instance exemestane, medroxyprogesterone acetate and estradiol cypionate or a combination of medroxyprogesterone acetate and estradiol cypionate.
Inventor(s): Colombo; Giuseppe (Milan, IT), Martini; Alessandro (Milan, IT), Fox; Lloyd E. (Richland, MI)
Assignee: Pharmacia & Upjohn SpA (Milan, IT) Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:09/571,395
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Composition; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Pharmacia And UpjohnDEPO-SUBQ PROVERA 104medroxyprogesterone acetateINJECTABLE;SUBCUTANEOUS021583-001Dec 17, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,495,534

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland203075► Subscribe
Poland365793► Subscribe
Peru13222001► Subscribe
New Zealand522324► Subscribe
Norway332215► Subscribe
Norway20025431► Subscribe
MexicoPA02011195► Subscribe
South Korea100828957► Subscribe
South Korea20030020280► Subscribe
Japan4205341► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: